Aflibercept – Setting Its Sights on Diabetic Macular Oedema

European Ophthalmic Review
doi 10.17925/eor.2014.08.02.152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Effect of Intravitreal Aflibercept on Recalcitrant Diabetic Macular Edema

International Journal of Retina and Vitreous
Ophthalmology
2017English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Diode Laser Photocoagulation for Diabetic Macular Oedema.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1995English

Argon Laser Photocoagulation for Diabetic Macular Oedema

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2006English

Comparison Between the Short-Term Outcomes of Bevacizumab and Ziv-Aflibercept in the Treatment of Primary Diabetic Macular Oedema

Acta Ophthalmologica
MedicineOphthalmology
2017English

Our Experience With Laser Photocoagulation in Diabetic Macular Oedema

Medical Journal Armed Forces India
Medicine
1997English

Diabetic Macular Oedema: Under-Represented in the Genetic Analysis of Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Costs Associated With the Management and Morbidity of Diabetic Macular Oedema and Macular Oedema Secondary to Retinal Vein Occlusion

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Diabetic Macular Oedema and the Importance of Vascular Endothelial Growth Factor Therapies in Its Treatment

European Ophthalmic Review
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy